~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Saturday, September 5, 2015
HSE to fund on limited basis cost of multiple sclerosis drug
Sept 3, 2015 - The Health Service Executive has agreed to fund on a limited basis the cost of a drug that helps people with multiple sclerosis to walk.
The announcement that Fampridine (known commercially as Fampyra) is to be reimbursed under the State-funded drugs schemes follows a lengthy campaign by patients who says the drug has greatly aided their mobility.
The HSE says it is in the final stages of putting in place the arrangement around a “responder-based” reimbursement programme for Fampridine.
MS Views and News helps to provide information for all affected by MS
Keep up to date with the news and information we provide
by signing up by clicking here